Review: Diagnosis and management of essential tremor and dystonic tremor

Essential tremor (ET) is the most common adult movement disorder. Traditionally considered as a benign disease, it can cause an important physical and psychosocial disability. Drug treatment for ET remains poor and often unsatisfactory. Current therapeutic strategies for ET are reviewed according to the level of discomfort caused by tremor. For mild tremor, nonpharmacological strategies consist of alcohol and acute pharmacological therapy; for moderate tremor, pharmacological therapies (propranolol, gabapentin, primidone, topiramate, alprazolam and other drugs); and for severe tremor, the role of functional surgery is emphasised (thalamic deep brain stimulation, thalamotomy). The more specific treatment of head tremor with the use of botulinum toxin is also discussed. Several points are discussed to guide the immediate research into this disease in the near future. Dystonic tremor is a common symptom in dystonia. Diagnostic criteria for dystonic tremor and differential diagnosis with psychogenic tremor and ET are described. Treatment of dystonic tremor matches the treatment of dystonia. In cases of symptomatic dystonic tremor similar to ET, therapeutic strategies would be the same as for ET.

[1]  J. Kulisevsky,et al.  Transcranial magnetic stimulation of the cerebellum in essential tremor: a controlled study. , 2002, Archives of neurology.

[2]  M Schulzer,et al.  Head Tremor in Cervical Dystonia , 2000, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[3]  R. Pahwa,et al.  Botulinum toxin treatment of essential head tremor , 1995, Neurology.

[4]  W. Koller,et al.  Acute and chronic effects of propranolol and primidone in essential tremor , 1989, Neurology.

[5]  N. Biary,et al.  The effect of nimodipine on essential tremor , 1995, Neurology.

[6]  J. Rothwell,et al.  Identification of psychogenic, dystonic, and other organic tremors by a coherence entrainment test , 2004, Movement disorders : official journal of the Movement Disorder Society.

[7]  C. Marsden,et al.  A Double‐Blind Trial of Clonazepam in Benign Essential Tremor , 1984, Clinical neuropharmacology.

[8]  C. Marsden,et al.  beta-Adrenoreceptor antagonists in essential tremor. , 1979, Journal of neurology, neurosurgery, and psychiatry.

[9]  R. Elble Report from a U.S. conference on essential tremor , 2006, Movement disorders : official journal of the Movement Disorder Society.

[10]  J D Speelman,et al.  Multicentre European study of thalamic stimulation in essential tremor: a six year follow up , 2003, Journal of neurology, neurosurgery, and psychiatry.

[11]  K. Lyons,et al.  Double‐blind controlled trial of gabapentin in essential tremor , 1998, Movement disorders : official journal of the Movement Disorder Society.

[12]  J. Kulisevsky,et al.  Routine Neurophysiologic Tremor Analysis as a Diagnostic Tool for Essential Tremor: A Prospective Study , 2004, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[13]  P. Piccini,et al.  Acute and chronic effects of clozapine in essential tremor , 1999, Movement disorders : official journal of the Movement Disorder Society.

[14]  J. Jankovic,et al.  Physiologic and pathologic tremors. Diagnosis, mechanism, and management. , 1980, Annals of internal medicine.

[15]  J. Hubble,et al.  Essential tremor. , 1989, Clinical neuropharmacology.

[16]  J. Jankovic,et al.  Gabapentin for essential tremor: A multiple‐dose, double‐blind, placebo‐controlled trial , 2000, Movement disorders : official journal of the Movement Disorder Society.

[17]  A. Chakrabarti,et al.  Essential tremor: response to primidone. , 1981, Journal of neurology, neurosurgery, and psychiatry.

[18]  C. Marsden,et al.  Intrafamilial correlation in idiopathic torsion dystonia , 1991, Movement disorders : official journal of the Movement Disorder Society.

[19]  R Cooper,et al.  A comparison of primidone, propranolol, and placebo in essential tremor, using quantitative analysis. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[20]  M. Brin,et al.  Consensus Statement of the Movement Disorder Society on Tremor , 2008, Movement disorders : official journal of the Movement Disorder Society.

[21]  C. Marsden,et al.  Adrenoreceptor antagonists in essential tremor , 2022 .

[22]  W. Ondo Zonisamide for Essential Tremor , 2007, Clinical neuropharmacology.

[23]  J. Jankovic,et al.  A randomized, double‐blind, placebo‐controlled study to evaluate botulinum toxin type A in essential hand tremor , 1996, Movement disorders : official journal of the Movement Disorder Society.

[24]  R. Elble,et al.  Primary writing tremor. A form of focal dystonia? , 1990, Movement disorders : official journal of the Movement Disorder Society.

[25]  Y. Agid,et al.  Tremor and idiopathic dystonia , 1991, Movement disorders : official journal of the Movement Disorder Society.

[26]  J. Kulisevsky,et al.  A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor. , 1999, Archives of neurology.

[27]  Jason L Salemi,et al.  A pilot, double‐blind, placebo‐controlled trial of pregabalin (Lyrica) in the treatment of essential tremor , 2007, Movement disorders : official journal of the Movement Disorder Society.

[28]  G. Paulson,et al.  Efficacy of alprazolam for essential tremor , 1988, Neurology.

[29]  I. Gich,et al.  Temblor postural: estudio clínico y neurofisiológico en una serie consecutiva de 300 pacientes , 2001 .

[30]  Rajesh Pahwa,et al.  Levetiracetam is Not Effective for Essential Tremor , 2007, Clinical neuropharmacology.

[31]  R Fava,et al.  Primidone in the long-term treatment of essential tremor: a prospective study with computerized quantitative analysis. , 1990, Clinical neuropharmacology.

[32]  R. Elble,et al.  CME Practice Parameter : Therapies for essential tremor Report of the Quality Standards Subcommittee of the American Academy of Neurology , 2005 .

[33]  Daniel Tarsy,et al.  Topiramate in Essential Tremor: Findings from Double-Blind, Placebo-Controlled, Crossover Trials , 2008, Clinical neuropharmacology.

[34]  R. Loewenson,et al.  Essential tremor , 1975, Neurology.

[35]  D. Vaillancourt,et al.  Deep brain stimulation of the VIM thalamic nucleus modifies several features of essential tremor , 2003, Neurology.

[36]  E. Louis,et al.  A single-blind, open-label trial of sodium oxybate for myoclonus and essential tremor , 2005, Neurology.

[37]  W. Koller,et al.  Effect of alcohol on tremors , 1984, Neurology.

[38]  L. Findley,et al.  Propranolol and propranolol-LA in essential tremor: a double blind comparative study. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[39]  R. Young,et al.  Gamma knife thalamotomy for treatment of tremor: long-term results. , 2000, Journal of neurosurgery.

[40]  L. Findley,et al.  Primidone in essential tremor of the hands and head: a double blind controlled clinical study. , 1985, Journal of neurology, neurosurgery, and psychiatry.